Sanuwave Health (NASDAQ:SNWV) Cut to Hold at Wall Street Zen

Wall Street Zen cut shares of Sanuwave Health (NASDAQ:SNWV) from a buy rating to a hold rating in a research note published on Saturday morning.

Several other equities analysts also recently commented on the stock. Northland Securities began coverage on shares of Sanuwave Health in a research note on Wednesday, September 3rd. They issued an “outperform” rating and a $55.00 price target for the company. Roth Capital set a $53.00 price target on shares of Sanuwave Health and gave the stock a “buy” rating in a research note on Tuesday, October 7th. Northland Capmk raised Sanuwave Health to a “strong-buy” rating in a research note on Wednesday, September 3rd. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Sanuwave Health in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $54.00.

Sanuwave Health Trading Up 3.4%

Shares of NASDAQ SNWV opened at $33.35 on Friday. The stock has a market capitalization of $285.81 million, a PE ratio of -4.04 and a beta of 1.33. The stock has a fifty day simple moving average of $37.44 and a 200-day simple moving average of $33.70. Sanuwave Health has a twelve month low of $5.63 and a twelve month high of $46.58.

Sanuwave Health (NASDAQ:SNWV) last released its earnings results on Friday, August 8th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.10. The firm had revenue of $10.16 million during the quarter, compared to analyst estimates of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in SNWV. Strategic Investment Solutions Inc. IL acquired a new position in shares of Sanuwave Health during the 1st quarter worth about $47,000. Solas Capital Management LLC acquired a new position in Sanuwave Health in the first quarter valued at approximately $20,658,000. AWM Investment Company Inc. acquired a new position in Sanuwave Health in the first quarter valued at approximately $18,153,000. Goldman Sachs Group Inc. acquired a new position in Sanuwave Health in the first quarter valued at approximately $337,000. Finally, Evernest Financial Advisors LLC acquired a new position in Sanuwave Health in the second quarter valued at approximately $823,000. 42.53% of the stock is owned by institutional investors and hedge funds.

About Sanuwave Health

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.